Variant report
Variant | esv3397700 |
---|---|
Chromosome Location | chr6:145903709-145906207 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs115379454 | chr6:145903743-145903744 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs547956679 | chr6:145903761-145903762 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs76631039 | chr6:145903762-145903763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs192630778 | chr6:145903773-145903774 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs545674447 | chr6:145903854-145903855 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs563965511 | chr6:145903889-145903890 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs375074261 | chr6:145903927-145903928 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs367998012 | chr6:145903953-145903954 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs369081605 | chr6:145904045-145904046 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs143798779 | chr6:145904118-145904119 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs183451572 | chr6:145904152-145904153 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs528956928 | chr6:145904182-145904183 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs550324238 | chr6:145904189-145904190 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs373373967 | chr6:145904203-145904204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs568855768 | chr6:145904230-145904231 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs188037967 | chr6:145904249-145904250 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs192455134 | chr6:145904262-145904263 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs184717133 | chr6:145904284-145904285 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs534914630 | chr6:145904292-145904293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs553482689 | chr6:145904323-145904324 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs148168893 | chr6:145904339-145904340 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs535908721 | chr6:145904381-145904382 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs6570692 | chr6:145904401-145904402 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
24 | rs201136915 | chr6:145904409-145904410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs76273490 | chr6:145904423-145904424 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs545737537 | chr6:145904426-145904427 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs564028836 | chr6:145904439-145904440 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs534253656 | chr6:145904457-145904458 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs200160176 | chr6:145904463-145904464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs540079207 | chr6:145904466-145904467 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs561889078 | chr6:145904506-145904507 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs189035029 | chr6:145904524-145904525 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs550629439 | chr6:145904537-145904538 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs562515632 | chr6:145904578-145904579 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs532949746 | chr6:145904616-145904617 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
36 | rs572243520 | chr6:145904637-145904638 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
37 | rs551357102 | chr6:145904645-145904646 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
38 | rs554232299 | chr6:145904656-145904657 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
39 | rs76788256 | chr6:145904703-145904704 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
40 | rs546893947 | chr6:145904724-145904725 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
41 | rs4335004 | chr6:145904764-145904765 | Enhancers ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
42 | rs535601336 | chr6:145904774-145904775 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
43 | rs192729512 | chr6:145904861-145904862 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
44 | rs575273599 | chr6:145904875-145904876 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
45 | rs529700546 | chr6:145904907-145904908 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
46 | rs147175354 | chr6:145904939-145904940 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
47 | rs145106727 | chr6:145904944-145904945 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
48 | rs78244375 | chr6:145904971-145904972 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
49 | rs573071821 | chr6:145904996-145904997 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
50 | rs557557020 | chr6:145905073-145905074 | ZNF genes & repeats Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Autism | 22495311 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Prostate cancer | 18632612 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Endocrine pancreatic tumor | 17914106 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Myelofibrosis | 22110671 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:145890600-145904600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr6:145904600-145905000 | Enhancers | H1 Cell Line | embryonic stem cell |
3 | chr6:145904600-145905000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
4 | chr6:145904600-145905200 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
5 | chr6:145904600-145905400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
6 | chr6:145904600-145905600 | ZNF genes & repeats | Lung | lung |
7 | chr6:145904800-145905000 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |
8 | chr6:145904800-145905200 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
9 | chr6:145904800-145905200 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
10 | chr6:145904800-145905200 | ZNF genes & repeats | Esophagus | oesophagus |
11 | chr6:145904800-145905200 | Enhancers | HMEC | breast |
12 | chr6:145904800-145905600 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
13 | chr6:145904800-145905600 | ZNF genes & repeats | Foreskin Melanocyte Primary Cells skin01 | Skin |
14 | chr6:145905000-145905400 | Bivalent Enhancer | Foreskin Fibroblast Primary Cells skin02 | Skin |
15 | chr6:145905200-145910200 | Weak transcription | Esophagus | oesophagus |
16 | chr6:145905600-145906000 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |